Short answer
TuHURA Biosciences, Inc./NV (HURA) filed an 8-K current report with the SEC on September 16, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Board adopted 2026 Inducement Equity Incentive Plan without shareholder approval under Nasdaq Rule 5635(c)(4).
TuHURA Biosciences, Inc./NV 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Board adopted 2026 Inducement Equity Incentive Plan without shareholder approval under Nasdaq Rule 5635(c)(4)
- 5,000,000 common shares reserved for equity awards to qualifying new employees
- Broad award types permitted, including options, restricted stock, units, performance awards and other stock-based compensation
- Potential shareholder dilution tied to future hiring, with awards administered by independent directors’ Compensation Committee
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other TuHURA Biosciences, Inc./NV 8-K filings
Get the next HURA 8-K as it lands
Follow HURA for push alerts, or ask the research agent what this filing means.